In vitro activity of linezolid against Clostridium difficile

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 5, 2002, Pages 1617-1618

  Ackermann, Grit ^a   Adler, Daniela ^a   Rodloff, Arne C ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; CLOSTRIDIUM DIFFICILE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG RESISTANCE, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; VANCOMYCIN RESISTANCE;

EID: 0036239818     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.5.1617-1618.2002     Document Type: Article

References (25)

1. Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea
2. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study
3. Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents
4. In vitro activity of linezolid (U-100766) against Haemophilus influenzae measured by three different susceptibility testing methods
5. 'Second-look' cytotoxicity: An evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD
6. In vitro activity of linezolid against multiply resistant gram-positive clinical isolates
7. Antibiotic resistance of Clostridium difficile isolates
8. In vitro activity of linezolid and eperezolid against anaerobic bacteria
9. Linezolid: An oxazolidinone antimicrobial agent
10. Aetiology of antimicrobial-agent-associated colitis
11. Clostridium difficile-associated diarrhea and colitis
12. Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains
13. Community-acquired Clostridium difficile infection
14. Clostridium difficile: Its disease and toxins
15. In vitro and in vivo activities of nitazoxanide against Clostridium difficile
16. Linezolid: A review of its use in the management of serious gram-positive infections
17. Linezolid breakpoints
18. Antibiotic-induced colitis: Implication of a toxin neutralised by Clostridium sordellii antitoxin
19. Community-acquired Clostridium difficile-associated diarrhea
20. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia
21. "Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy
22. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of drug
23. Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest